Estrogen/progestogen fails to enhance QOL

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1379, 2003-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Estrogen/progestogen fails to enhance QOL

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 404, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Monophasic Estrogen-Progestogen Therapy and Sexuality in Postmenopausal Women

By Fonseca A.M. Bagnoli V.R. Penteado S.R.L. Paixão J.S. Cavalcanti A.L. Pinotti J.A.

Clinical Drug Investigation, Vol. 27, Iss. 2, 2007-01 ,pp. : 131-137

Adis International

Access to resources Recommend Favorite

Estrogen/progestogen: decreased colorectal cancer risk

Inpharma, Vol. 1, Iss. 1428, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Estrogen/progestogen: higher breast cancer risk than estrogen only

Inpharma, Vol. 1, Iss. 1223, 2000-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Estrogen/progestogen: increased breast cancer risk, lack of benefit

Inpharma, Vol. 1, Iss. 1346, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite